Patents by Inventor Miya Howell
Miya Howell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240254501Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.Type: ApplicationFiled: February 22, 2024Publication date: August 1, 2024Applicant: Monsanto Technology LLCInventors: Brent BROWER-TOLAND, Shunhong DAI, Karen GABBERT, Alexander GOLDSHMIDT, Miya HOWELL, Brad MCDILL, Dan OVADYA, Beth SAVIDGE, Vijay SHARMA
-
Publication number: 20230159946Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.Type: ApplicationFiled: November 28, 2022Publication date: May 25, 2023Applicant: Monsanto Technology LLCInventors: Brent BROWER-TOLAND, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya Howell, Brad Mcdill, Dan Ovadya, Beth Savidge, Vijay Sharma
-
Publication number: 20230110884Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: ApplicationFiled: June 22, 2022Publication date: April 13, 2023Applicant: MONSANTO TECHNOLOGY LLCInventors: Edwards Allen, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Silvalinganna MANJUNATH, Anil NEELAM, Linda RYMARQUIS, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG
-
Patent number: 11555201Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.Type: GrantFiled: October 18, 2017Date of Patent: January 17, 2023Assignee: Monsanto Technology LLCInventors: Brent Brower-Toland, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya Howell, Brad McDill, Dan Ovadya, Beth Savidge, Vijay Sharma
-
Publication number: 20220364108Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: ApplicationFiled: April 5, 2022Publication date: November 17, 2022Applicant: MONSANTO TECHNOLOGY LLCInventors: Edwards M. ALLEN, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Sivalinganna MANJUNATH, Anil NEELAM, Linda RYMARQUIS, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG
-
Patent number: 11414670Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: GrantFiled: April 13, 2020Date of Patent: August 16, 2022Assignee: Monsanto Technology LLCInventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Anil Neelam, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang, Sivalinganna Manjunath, Linda Rymarquis
-
Patent number: 11319550Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: GrantFiled: April 13, 2020Date of Patent: May 3, 2022Assignee: Monsanto Technology LLCInventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Anil Neelam, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang, Sivalinganna Manjunath, Linda Rymarquis
-
Publication number: 20200248200Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: ApplicationFiled: April 13, 2020Publication date: August 6, 2020Applicant: MONSANTO TECHNOLOGY LLCInventors: Edwards M. ALLEN, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Anil NEELAM, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG, Sivalinganna MANJUNATH, Linda RYMARQUIS
-
Publication number: 20200248199Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: ApplicationFiled: April 13, 2020Publication date: August 6, 2020Applicant: MONSANTO TECHNOLOGY LLCInventors: Edwards M. ALLEN, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Anil NEELAM, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG, Sivalinganna MANJUNATH, Linda RYMARQUIS
-
Patent number: 10724047Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: GrantFiled: August 17, 2017Date of Patent: July 28, 2020Assignee: MONSANTO TECHNOLOGY LLCInventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Sivalinganna Manjunath, Anil Neelam, Linda Rymarquis, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang
-
Publication number: 20180105819Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.Type: ApplicationFiled: October 18, 2017Publication date: April 19, 2018Inventors: Brent BROWER-TOLAND, Shunhong DAI, Karen GABBERT, Alexander GOLDSHMIDT, Miya HOWELL, Brad MCDILL, Dan OVADYA, Beth SAVIDGE, Vijay SHARMA
-
Publication number: 20180051295Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.Type: ApplicationFiled: August 17, 2017Publication date: February 22, 2018Applicant: MONSANTO TECHNOLOGY LLCInventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Anil Neelam, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang